news
Removing a protein slows the growth of tumour blood vessels
1 July 2015 | By Victoria White
Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain...
List view / Grid view
Hit-to-Lead
news
Research reveals new insights into a key antibiotic target in the fight against TB
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
news
Siemens and BioNTech cooperate on production of personalised cancer vaccines
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
news
Invenra and Oxford BioTherapeutics enter collaboration to discover novel therapeutic antibodies targeting cancer
26 June 2015 | By Victoria White
Invenra and Oxford BioTherapeutics are to collaborate to identify and characterise a panel of fully human therapeutic mAbs against a novel cancer target...
news
UCL scientists design compound that shrinks pancreatic cancer tumours and prevents regrowth
25 June 2015 | By Victoria White
Scientists from University College London have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80% in treated mice...
news
Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
news
ViraTherapeutics raises €3.6 million to advance its lead product VSV-GP
24 June 2015 | By Victoria White
ViraTherapeutics has announced the first closing of a Series A financing round, raising €3.6 million that it will use to advance its lead product VSV-GP...
news
Novogen’s Anisina on track to enter the clinic in 2016
24 June 2015 | By Victoria White
Novogen has announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals...
news
AYOXXA and Grünenthal complete research collaboration
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
news
Blueprint Medicines announces first preclinical data for BLU6864
23 June 2015 | By Victoria White
Blueprint Medicines has announced the first preclinical data for its drug candidate BLU6864, a RET-specific kinase inhibitor.
video
The Science of Affimers
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
video
Affimers and Therapeutic Applications
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
news
PSMA-617 can be used to irradiate prostate cancer cells from the inside
22 June 2015 | By Victoria White
Scientists at the German Cancer Research Centre have developed an agent, PSMA-617, which is capable of attaching specifically to prostate cancer cells...
news
Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
video
An Introduction to Avacta Life Sciences
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
